A real-world comparison of effectiveness and safety outcomes between clinical trial eligible and ineligible patients in the British Association of Dermatologists Biologic Interventions Register (BADBIR)

Mason, Kayleigh J.

All Outputs (5)

Psoriasis and COVID-19: findings from PsoProtectMe. (2023)
Conference Proceeding
McGrath, C., Yates, M., Yiu, Z., Langan, S., Tsakok, T., Dand, N., …Mahil, S. (2023). Psoriasis and COVID-19: findings from PsoProtectMe. . https://doi.org/10.55788/819f9152

Drug survival of biologics across age groups: an analysis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR), on behalf of the BADBIR study group (2022)
Conference Proceeding
Alabas, O., Mason, K., Yiu, Z., Warren, R., & Griffiths, C. (2022). Drug survival of biologics across age groups: an analysis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR), on behalf of the BADBIR study group.

HLA-C*06:02 allele is associated with higher drug survival in patients with psoriasis on ustekinumab: an analysis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR), on behalf of the BADBIR and BSTOP study groups (2022)
Conference Proceeding
Alabas, O., Mason, K., Yiu, Z., Warren, R., Dand, N., Barker, J., …Griffiths, C. (2022). HLA-C*06:02 allele is associated with higher drug survival in patients with psoriasis on ustekinumab: an analysis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR), on behalf of the BADBIR and BSTOP study groups.

The impact of the COVID-19 pandemic on people with psoriasis: findings from a global patient-reported registry (2021)
Conference Proceeding
Mahil, S., Yates, M., Yiu, Z., Langan, S., Tsakok, T., Dand, N., …Smith, C. (2021). The impact of the COVID-19 pandemic on people with psoriasis: findings from a global patient-reported registry.

A real-world comparison of effectiveness and safety outcomes between clinical trial eligible and ineligible patients in the British Association of Dermatologists Biologic Interventions Register (BADBIR) (2018)
Conference Proceeding
Mason, K. J. (2018). A real-world comparison of effectiveness and safety outcomes between clinical trial eligible and ineligible patients in the British Association of Dermatologists Biologic Interventions Register (BADBIR).

Background: There is preliminary evidence that psoriasis patients eligible for clinical trials of biologics are not representative of real-world patients. Objectives: To determine whether patients enrolled in BADBIR identified as eligible or ineli... Read More about A real-world comparison of effectiveness and safety outcomes between clinical trial eligible and ineligible patients in the British Association of Dermatologists Biologic Interventions Register (BADBIR).